Histologic and cytologic changes in normal equine joints after injection with 2.5% injectable polyacrylamide hydrogel reveal low-level macrophage-driven foreign body response

Supporting Better Long-Term Joint Outcomes

Access clinical information, educational resources and ongoing support from the Arthramid^® team.

Contact Our Team

Start with the Synovium. Start with Arthramid.
Pioneering the advancement of equine joint health.

Canine Vets
Equine Vets
Dog Owners
Horse Owners
Contact

Registered in Australia to: IMS Vet Pty Limited. Registered pursuant to the APVMA Number 86728/0320. See www.apvma.gov.au for registration conditions.

For use only by a veterinarian. Ask your vet to contact us today.

Level 40, Governor Macquarie Tower
1 Farrer Place
Sydney, NSW 2000
Australia

+61 (1800) 931 812

sales.anz@conturavet.com

Australia

USA
New Zealand
Europe

Terms & Conditions
Cookie Policy
Privacy Policy

Get The White Paper

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Email(Required)

Phone

Practice Name

Consent(Required)

By submitting this form you agree to receive communications from Arthramid. You can unsubscribe at any time by clicking the unsubscribe link in any email we send you. For more information on how we handle your data, please see our Privacy Policy (linked in footer)

Secret Link

Histologic and cytologic changes in normal equine joints after injection with 2.5% injectable polyacrylamide hydrogel reveal low-level macrophage-driven foreign body response

Supporting Better Long-Term Joint Outcomes

Access clinical information, educational resources and ongoing support from the Arthramid® team.

Get The White Paper

Access clinical information, educational resources and ongoing support from the Arthramid^® team.